Home » Topics » Regulatory

Regulatory
RSS

FDA expands approval of Vonvendi to include perioperative management of bleeding in adults with VWD

April 18, 2018

European Commission approves Kineret for the treatment of Still's disease

April 11, 2018

European Commission grants marketing authorization to Lamzede

April 6, 2018

FDA approves Leukine for H-ARS

April 3, 2018

Sujanu combination tablets approved in Japan

March 28, 2018

Velcade approved in Japan for primary macroglobulinemia and lymphoplasmacytic lymphoma

March 27, 2018

Hernicore approved in Japan to treat lumbar disc herniation

March 27, 2018

Japanese approval for Orkedia

March 27, 2018

Lenvima approved in Japan for unresectable HCC

March 26, 2018

European Commission approves Alofisel

March 26, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for July 16, 2025.
Atai Therapeutics discovers new 5-HT2A receptor partial agonists
BioWorld Science
Atai Therapeutics Inc. has synthesized new tetrahydro pyridine-substituted indole and azaindoles acting as 5-HT2A receptor partial agonists reported to be useful...
PHD inhibitors reported in Akebia Therapeutics patent
BioWorld Science
Akebia Therapeutics Inc. has identified new derivatives of ([1,2,4]triazolo[5,1-a]isoquinoline-5-carbonyl)glycinate acting as prolyl 4-hydroxylase (PHD) inhibitors.
FDA wants more data for Otsuka’s sNDA in PTSD
BioWorld
The U.S. FDA is insisting that another study is needed to bolster the sNDA for Rexulti (brexpiprazole) from Otsuka Pharmaceutical Co. Ltd. in treating adults with...